tiprankstipranks
Trending News
More News >

ETF 2025 - New Portfolio

Sazzad Alam

ETF 2025
Individual Investor
Ranked #86,521 out of 833,213 TipRanks' Investors
Success Rate
68%
199 out of 292
profitable transactions
Average Return
27.13%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 9.49%
6-Month Return▲ 53.25%
12-Month Return-
YTD Return▲ 60.21%
Total Return▲ 60.21%

Best Trade

Opened at
Closed at-
Gain▲ 240.55%

Bio

Performance

27.06%0-27.06%
▲ 11.63%
▲ 6.28%
▲ 0.77%
May 2025
▲ 9.25%
▲ 5.14%
▲ 9.04%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 9.23%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 4.37%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 27.06%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 25.07%
Oct 2025
▼ 3.57%
▲ 0.19%
▼ 17.37%
Nov 2025
▼ 0.06%
▼ 0.12%
▼ 2.60%
Dec 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 11.63%▲ 6.28%▲ 0.77%
▲ 9.25%▲ 5.14%▲ 9.04%
▲ 7.60%▲ 2.30%▲ 9.23%
▲ 2.76%▲ 2.05%▲ 4.37%
▲ 12.88%▲ 3.56%▲ 27.06%
▲ 10.96%▲ 2.38%▲ 25.07%
▼ 3.57%▲ 0.19%▼ 17.37%
▼ 0.06%▼ 0.12%▼ 2.60%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Arcturus Therapeutics
▼ 62.42%
2
Close
Nov 17, 2025
Tourmaline Bio
▲ 135.62%
6
Close
Oct 27, 2025
Amprius Technologies Inc
4.24%
▲ 25.19%
12
Buy
Sep 24, 2025
Adobe
▲ 1.12%
2
Close
Sep 24, 2025
Rigetti Computing
3.31%
▲ 49.56%
14
Buy
Sep 23, 2025
Riot Platforms
0%
▲ 39.67%
8
Sell
Sep 23, 2025
Broadcom
3.85%
▲ 22.02%
4
Buy
Sep 23, 2025
AppLovin
1.88%
▲ 98.01%
7
Sell
Sep 23, 2025
BigBearai Holdings
0.55%
▲ 29.52%
6
Open
Sep 23, 2025
DraftKings
▲ 4.69%
5
Close
Sep 23, 2025
Applied Digital Corporation
6.66%
▲ 117.50%
9
Buy
Sep 23, 2025
Oklo Inc
3.26%
▲ 0.67%
10
Buy
Sep 23, 2025
Marvell
0%
▲ 16.05%
6
Sell
Sep 23, 2025
Sagimet Biosciences, Inc. Class A
0.82%
▼ 12.01%
3
Buy
Sep 23, 2025
D-Wave Quantum
5.85%
▲ 61.27%
15
Buy
Sep 22, 2025
NuScale Power
0%
▼ 55.49%
8
Sell
Sep 22, 2025
Viking Therapeutics
0.64%
▲ 34.06%
1
Open
Sep 22, 2025
Cipher Mining
4.67%
▲ 135.72%
11
Buy
Sep 20, 2025
IREN
5.24%
▲ 82.24%
10
Buy
Sep 20, 2025
Veritone
0%
▼ 12.11%
1
Open
Sep 20, 2025